- Building Industries For A Better Tomorrow | SK
SK is a global leader driving economic and social prosperity through innovative solutions Discover our cutting-edge companies and sustainable practices
- SK Groups Holding Company Investment Leader | SK Inc. | SK
SK Inc is building a better future by investing globally in semiconductors, batteries, AI, and biopharmaceuticals to drive social value and sustainable growth
- Discover Our U. S. Investment and Operations Map | SK
In more than 20 states across the U S , SK is investing in businesses and expanding our local operations in electric vehicle batteries, life sciences, technology solutions, semiconductors, and sustainable energy
- Investing In Industries Around The Globe | Learn More | SK
About SK At SK, we have a vision for better We invest in game-changing businesses and nurture them for long-term success Whether it’s in life sciences, semiconductors, or sustainable energy, we rally behind the people, industries, and places that drive better growth and create meaningful change
- Learn How Our Companies Make A Global Impact | SK
We operate more than 175 companies across the energy, life sciences, advanced materials, mobility, and semiconductors industries As part of the broader SK network, we also have access to global perspectives and resources that help us fulfill our vision for each of the markets we’re in
- The Latest News From SK | The Drive For Better | SK
Stay updated with SK's latest news and press releases Explore our media resources for the latest on our global initiatives and achievements
- SK Expands its Operations and Strategic Investments in the U. S.
In the U S , SK’s presence continues to grow as new facilities open, and strategic investments and partnerships expand SK companies have operated in the U S for the past three decades and today we have more than 6,000 local employees
- Global Pharmaceutical Manufacturing | SK Pharmteco | SK
SK pharmteco is a global CDMO specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy
|